Bacteria: How Legionella defend their turf

Communities of bacteria that cause Legionnaire’s disease repel other bacteria by secreting an acid called HGA.
  1. Elisa D Hughes
  2. Michele S Swanson  Is a corresponding author
  1. University of Michigan Medical School, United States

Legionella pneumophila is a water-borne bacterium that takes up residence in engineered water systems, and if inhaled by susceptible people, it can cause a severe form of pneumonia known as Legionnaires’ disease. According to the Centers for Disease Control and Prevention, L. pneumophila infections are on the rise and are now the leading cause of water-associated illness in the United States. However, a major problem is that decontamination methods often fail to eradicate every single bacterium, which allows populations of bacteria to build up again (Cervero-Aragó et al., 2015; Berjeaud et al., 2016).

One way that Legionella manages to persist in the environment is by associating with biofilms – microbial communities that attach to surfaces and encase themselves in a protective matrix (Abu Khweek and Amer, 2018). The microbes in these communities engage in behaviors that mutually benefit each other, such as forming food chains or making up the sugar chains of the biofilm’s protective shield (Elias and Banin, 2012). Inhabitants of the biofilm must also repel other microbes that are unlikely to contribute to the community (Drescher et al., 2014; Özkaya et al., 2017). However, despite these biofilms being a threatening pool of infectious bacteria, little is known about how L. pneumophila socially behave. Now, in eLife, Tera Levin, Brian Goldspiel and Harmit Malik from the Fred Hutchinson Cancer Research Center report how highly dense populations of L. pneumophila can inhibit the growth of other bacteria belonging to the same or related species of Legionella (Levin et al., 2019).

Levin et al. found that L. pneumophila secrete a molecule called homogenetisic acid, or HGA for short, which is produced by the amino acids tyrosine and phenylalanine as they convert into more complex molecules. Legionella primarily secretes HGA after the bacteria have stopped replicating, during a period known as the stationary phase. Once secreted, HGA combines with oxygen and self-assembles into long chains to form a dark brown pigment. This pigment, called pyomelanin, is known to protect Legionella against light damage and to help them acquire iron, which is an essential micronutrient (Steinert et al., 1995; Zheng et al., 2013). Levin et al. show that HGA also has toxic properties that can defend Legionella communities from invading microbes.

These properties became evident when the researchers discovered that L. pneumophila mutants that fail to inhibit the growth of other Legionella bacteria did not produce HGA. Interestingly, secreted HGA is only toxic if oxygen is present in the environment, and Levin et al. argue that a reactive intermediate formed during the conversion of HGA to pyomelanin likely accounts for its inhibitory properties. HGA is also detoxified by reducing agents, including the amino acid cysteine, which must be present for L. pneumophila to grow in laboratory cultures.

One conundrum is how L. pneumophila avoids the toxic effects of HGA. As secretion of the inhibitor increases when the bacteria are in the stationary phase – a state typically associated with high bacterial density – Levin et al. speculated that genes involved in either quorum sensing (which leads to changes in gene regulation based on population density) or the stringent stress response may promote resistance to HGA. However, deleting known genes in each of these widespread cell-signaling pathways does not alter resistance or susceptibility to HGA. Instead, L. pneumophila cells are only susceptible to inhibition when at low density, regardless of whether they are in the stationary or replicating phase. It therefore remains to be discovered how individual L. pneumophila cells at high density protect themselves from HGA.

Thinking about the natural habitats of L. pneumophila, Levin et al. envision individual bacterial cells sticking to a surface, such as the interior of a water pipe (Figure 1). As L. pneumophila begin to replicate, they form a small colony, then grow to form a large cooperative community, likely sharing resources liberated by digestive enzymes that they have secreted (White and Cianciotto, 2019). After reaching a certain density, the residents protect their turf from other bacteria by releasing a pulse of HGA. Since the high concentration of bacteria in the colony also triggers resistance to HGA, the community is automatically protected from the inhibitor.

High-density colonies of Legionella protect themselves by secreting pulses of HGA.

The development of Legionella colonies begins with individual cells adhering to a surface, such as the inside of a water pipe. After reaching a certain density, the bacteria intensify the secretion of HGA, which prevents other Legionella cells from joining the colony. Image credit: Elisa D. Hughes (CC BY 4.0).

The work of Levin, Goldspiel and Malik provides an important insight into how Legionella persist within microbial communities, and also identifies several questions that warrant further investigation. First, as biofilms comprised of a single species are not common in nature (Elias and Banin, 2012), it would be useful to know more about the impact of HGA on non-Legionella bacteria. In addition, understanding how the reactive intermediate of HGA is able to inhibit Legionella, and how individuals within dense colonies of the pathogen acquire resistance, could significantly advance the broad field of microbiology ecology. Finally, it is tempting to speculate that the HGA inhibition and resistance pathways discovered by Levin et al. could help identify new ways of eliminating pathogenic Legionella from engineered water systems.

References

    1. Steinert M
    2. Engelhard H
    3. Flügel M
    4. Wintermeyer E
    5. Hacker J
    (1995)
    The lly protein protects Legionella pneumophila from light but does not directly influence its intracellular survival in Hartmannella vermiformis
    Applied and Environmental Microbiology 61:2428–2430.

Article and author information

Author details

  1. Elisa D Hughes

    Elisa D Hughes is in the Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, United States

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4897-8094
  2. Michele S Swanson

    Michele Swanson is in the Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, United States

    For correspondence
    mswanson@umich.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2542-0266

Publication history

  1. Version of Record published: June 28, 2019 (version 1)

Copyright

© 2019, Hughes and Swanson

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 854
    Page views
  • 82
    Downloads
  • 3
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Elisa D Hughes
  2. Michele S Swanson
(2019)
Bacteria: How Legionella defend their turf
eLife 8:e48695.
https://doi.org/10.7554/eLife.48695

Further reading

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Liselot Dewachter et al.
    Research Article

    Antibiotic resistance in the important opportunistic human pathogen Streptococcus pneumoniae is on the rise. This is particularly problematic in the case of the β-lactam antibiotic amoxicillin, which is the first-line therapy. It is therefore crucial to uncover targets that would kill or resensitize amoxicillin-resistant pneumococci. To do so, we developed a genome-wide, single-cell based, gene silencing screen using CRISPR interference called sCRilecs-seq (subsets of CRISPR interference libraries extracted by fluorescence activated cell sorting coupled to next generation sequencing). Since amoxicillin affects growth and division, sCRilecs-seq was used to identify targets that are responsible for maintaining proper cell size. Our screen revealed that downregulation of the mevalonate pathway leads to extensive cell elongation. Further investigation into this phenotype indicates that it is caused by a reduced availability of cell wall precursors at the site of cell wall synthesis due to a limitation in the production of undecaprenyl phosphate (Und-P), the lipid carrier that is responsible for transporting these precursors across the cell membrane. The data suggest that, whereas peptidoglycan synthesis continues even with reduced Und-P levels, cell constriction is specifically halted. We successfully exploited this knowledge to create a combination treatment strategy where the FDA-approved drug clomiphene, an inhibitor of Und-P synthesis, is paired up with amoxicillin. Our results show that clomiphene potentiates the antimicrobial activity of amoxicillin and that combination therapy resensitizes amoxicillin-resistant S. pneumoniae. These findings could provide a starting point to develop a solution for the increasing amount of hard-to-treat amoxicillin-resistant pneumococcal infections.

    1. Microbiology and Infectious Disease
    Dallas L Mould et al.
    Research Article Updated

    Microbes frequently evolve in reproducible ways. Here, we show that differences in specific metabolic regulation rather than inter-strain interactions explain the frequent presence of lasR loss-of-function (LOF) mutations in the bacterial pathogen Pseudomonas aeruginosa. While LasR contributes to virulence through its role in quorum sensing, lasR mutants have been associated with more severe disease. A model based on the intrinsic growth kinetics for a wild type strain and its LasR derivative, in combination with an experimental evolution based genetic screen and further genetics analyses, indicated that differences in metabolism were sufficient to explain the rise of these common mutant types. The evolution of LasR lineages in laboratory and clinical isolates depended on activity of the two-component system CbrAB, which modulates substrate prioritization through the catabolite repression control pathway. LasR lineages frequently arise in cystic fibrosis lung infections and their detection correlates with disease severity. Our analysis of bronchoalveolar lavage fluid metabolomes identified compounds that negatively correlate with lung function, and we show that these compounds support enhanced growth of LasR cells in a CbrB-controlled manner. We propose that in vivo metabolomes contribute to pathogen evolution, which may influence the progression of disease and its treatment.